110 results match your criteria: "Affymax Research Institute[Affiliation]"
Expert Opin Investig Drugs
August 1998
Affymax Research Institute, Santa Clara, CA 95051, USA.
The emergence of pathogens resistant to currently available treatments is seen as a public health crisis. Since few new classes of antimicrobial drugs have been developed in the last two decades, it is becoming increasingly probable that healthcare providers will be faced with infections for which no chemotherapeutic agent is available. A renewed emphasis is being placed on employing the most advanced drug discovery technologies in the development of new antimicrobials.
View Article and Find Full Text PDFJ Comb Chem
May 2004
Affymax Research Institute, 4001 Miranda Avenue, Palo Alto, CA 94304, USA.
The design, synthesis, characterization, and screening of a large, encoded thiazolidinone library are described. Three sets of 35 building blocks were combined by encoded split-pool synthesis to give a library containing more than 42 000 members. Building block selection was based in part on a novel small molecule follicle stimulating hormone receptor agonist hit and in part for diversity.
View Article and Find Full Text PDFJ Org Chem
February 2004
Affymax Research Institute, 3410 Central Expressway, Santa Clara, California 95051, USA.
An efficient approach to rigid tricyclic nitrogen heterocycles via sequential and tandem Ugi/intramolecular Diels-Alder (IMDA) cycloaddition of pyrrole is described. The one-pot Ugi four-component condensation (4CC) reaction was used as the key transformation to prepare trienes with a carboxamide substituent on the tether. The use of acrylic acid (21) and N-propyl- and N-benzylmaleamic acids (24b and 24C) as the acid components provided trienes 22, 25b, and 25c, respectively, which upon heating at 120 degrees C for 12 h yielded the corresponding [4 + 2] cycloaddition products.
View Article and Find Full Text PDFJ Am Chem Soc
August 2003
Affymax Research Institute, 4001 Miranda Avenue, Palo Alto, California 94304, USA.
A novel synthetic stratetegy for compounds labeled with the positron-emitting isotope carbon-11 is described. The use of precursors attached to a solid support via safety-catch linkers allows selective release of radiolabeled material, leaving unreacted precursor attached to the support. Two different linkers demonstrate the application to the preparation of radiolabeled N-alkyl tertiary amines and N-alkylsulfonamides.
View Article and Find Full Text PDFEur J Nucl Med Mol Imaging
September 2003
Affymax Research Institute, Palo Alto, CA, USA.
Imaging of gene expression in vivo has many potential uses for biomedical research and drug discovery, ranging from the study of gene regulation and cancer to the non-invasive assessment of gene therapies. To streamline the development of imaging marker gene technologies for nuclear medicine, we propose a new approach to the design of reporter/probe pairs wherein the reporter is a cell surface-expressed single chain antibody variable fragment that has been raised against a low molecular weight imaging probe with optimized pharmacokinetic properties. Proof of concept of the approach was achieved using a single chain antibody variable fragment that binds with high affinity to fluorescein and an imaging probe consisting of fluorescein isothiocyanate coupled to the chelator diethylene triamine penta-acetic acid labeled with the gamma-emitter (111)In.
View Article and Find Full Text PDFComb Chem High Throughput Screen
November 2002
Affymax Research Institute, 4001 Miranda Ave, Palo Alto, CA 94304, USA.
This paper describes the applications which are used to automate the analysis of encoded combinatorial libraries. Commercial packages from MDL, Oracle and Agilent are linked with application software written in C/C++, in Microsoft Access and in ChemStation macro language. Encoding correspondence lists for each of up to three synthetic steps are conveniently associated with building block lists using the first application, CodeGen.
View Article and Find Full Text PDFAngew Chem Int Ed Engl
December 2001
Department of Chemistry, Affymax Research Institute 4001 Miranda Avenue, Palo Alto, CA 94304 (USA).
Funct Integr Genomics
September 2000
Affymax Research Institute, 3410 Central Expressway, Santa Clara, CA 95051, USA.
In order to investigate gene expression changes associated with cytotoxicity, we used cDNA arrays to monitor the expression of over 5,000 genes in response to toxic stress in the HepG2 liver cell line. Cells were treated with cytotoxic doses of acetaminophen, caffeine or thioacetamide for nine time points ranging from 1 to 24 h. Samples of mRNA from each time point were used to prepare radiolabeled cDNA, which was hybridized to nylon-membrane-based cDNA arrays.
View Article and Find Full Text PDFJ Biol Chem
February 2002
Affymax Research Institute, Palo Alto, California 94304, USA.
Based on the kinetic model of substrate phage proteolysis, we have formulated a strategy for best manipulating the conditions in screening phage display libraries for protease substrates (Sharkov, N. A., Davis, R.
View Article and Find Full Text PDFCurr Opin Drug Discov Devel
January 2001
Affymax Research Institute, 4001 Miranda Ave, Palo Alto, CA 94304, USA.
The sequence of the human genome will soon provide researchers with hundreds of new ion channel genes. To create a successful ion channel drug discovery program, it is necessary to quickly develop reliable and robust high-throughput screening (HTS) assays for those ion channels implicated in important diseases. Ion channels are dynamic proteins, and therefore require assays that 'sense' their various functional states.
View Article and Find Full Text PDFJ Org Chem
October 1999
Affymax Research Institute, 3410 Central Expressway, Santa Clara, California 95051.
Sequential pyrrolidine and hydantoin ring-forming reactions have been applied in the stereoselective solid-phase synthesis of a conformationally constrained, tricyclic triazacyclopenta[c]pentalene scaffold. These novel compounds share the structural complexity characteristic of certain alkaloid natural products and represent a source of chemical diversity that complements more traditional classes of heterocyclic compounds of interest as potential pharmaceutical agents. They are assembled in a 12-step reaction sequence from 4 variable building blocks by combining an intramolecular azomethine ylide cycloaddition reaction with a final cyclative cleavage from resin.
View Article and Find Full Text PDFJ Org Chem
November 1997
Affymax Research Institute, 3410 Central Expressway, Santa Clara, California 95051.
Solid-phase synthesis of beta-sultams amenable for construction of sulfonyl beta-lactam analogue combinatorial libraries is reported. Imine intermediates generated from polymer-immobilized amino acids and aldehydes are reacted with (chlorosulfonyl)acetates in the presence of pyridine to afford the solid-phase-tethered beta-sultam products. The latter can be released from support by acidic cleavage (TFA) or photocleavage, depending on the nature of the linker employed (acid-labile or photolabile linkers).
View Article and Find Full Text PDFOrg Lett
September 2001
Affymax Research Institute, 4001 Miranda Avenue, Palo Alto, California 94304, USA.
A new strategy for the solid-phase synthesis of sulfonamides is described. The Kenner safety-catch strategy has been modified such that the carboxylic acid component remains attached to the solid support while the sulfonamide portion is released into solution. An initial demonstration of the scope of this strategy is presented, along with an analysis of the cleavage characteristics and extension to more elaborate products via Suzuki reaction and thiazolidinone synthesis.
View Article and Find Full Text PDFJ Chromatogr A
July 2001
Affymax Research Institute, Santa Clara, CA, 95051, USA.
LC-fluorescence and LC-MS methods have been previously reported for use in decoding bead-based combinatorial libraries. We present the use of capillary electrochromatography (CEC) for highly selective decoding in combination with laser-induced fluorescence (LIF) detection for high sensitivity. The results are compared to prior data obtained using HPLC with fluorescence detection.
View Article and Find Full Text PDFOrg Lett
August 2001
Affymax Research Institute, 4001 Miranda Avenue, Palo Alto, California 94304, USA.
[reaction: see text]. The synthesis of a novel perfluoroalkylsulfonyl (PFS) fluoride is described for use as a traceless linker in solid-phase organic synthesis. Attachment to the resin and subsequent coupling of a phenol affords a stable arylsulfonate that behaves as a support-bound aryl triflate.
View Article and Find Full Text PDFJ Pharm Pharmacol
July 2001
Affymax Research Institute, Santa Clara, CA 95051, USA.
Prediction of the fraction of dose absorbed from the intestine (Fa) in man is essential in the early drug discovery stage. In-vitro assays in Caco-2 and MDCK cells are routinely used for that purpose, and their predictive value has been reported. However, in-situ techniques might provide a more accurate estimation of Fa.
View Article and Find Full Text PDFOrg Lett
January 2001
Affymax Research Institute, 4001 Miranda Avenue, Palo Alto, California 94304, USA.
[figure: see text] A solid-phase route to substituted benzimidazoles has been developed using a modified base-labile linker strategy to release the final products in a traceless manner. This approach permits the synthesis of diverse compounds in moderate yields and high purity.
View Article and Find Full Text PDFComb Chem High Throughput Screen
May 2001
Affymax Research Institute, 4001 Miranda Avenue, Palo Alto, CA 94304, USA.
An on-line sample preparation method utilizing a time-programmed autosampler is described for high throughput liquid chromatography/mass spectrometry (LC/MS). This approach is particularly helpful for the LC/MS analysis of samples which require solvents incompatible with HPLC in the sample preparation process. The on-line sample preparation approach minimizes a bottleneck in throughput and improves sample recovery under some circumstances.
View Article and Find Full Text PDFJ Pharm Sci
April 2001
Affymax Research Institute (A Glaxo Wellcome Company), 3410 Central Expressway, Santa Clara, CA 95051, USA.
Rapid methods for ranking the solubility of compounds in aqueous media using commercial, 96-well ultraviolet-visible (UV-vis) and nephelometric plate readers are described. The methods were evaluated using commercially available compounds from a variety of structural classes as well as a series of structurally related compounds derived from combinatorial synthesis. Samples were predissolved in dimethyl sulfoxide (DMSO) and then added to the study solvent to attain a final concentration of DMSO in the aqueous solution of 5%.
View Article and Find Full Text PDFJ Biol Chem
April 2001
Affymax Research Institute, Santa Clara, California 95051, USA.
Peptide libraries generated using phage display have been widely applied to proteolytic enzymes for substrate selection and optimization, but the reaction kinetics between the enzyme and substrate phage are not well understood. Using a quantitative ELISA assay to monitor the disappearance of substrate, we have been able to follow the course of reaction between stromelysin, a metalloprotease, and its substrate phage. We found that under the proteolytic conditions where the enzyme was present in nanomolar concentration or higher, in excess over the substrate, the proteolysis of substrate phage was a single exponential event and the observed rate linear with respect to enzyme concentration.
View Article and Find Full Text PDFAnal Chem
November 2000
Affymax Research Institute, Palo Alto, California 94304, USA.
Mass spectrometry combined with liquid chromatography (LC/MS) has become an important analytical methodology in both pharmaceutical and biomolecule analyses. LC/MS, especially with reversed-phase HPLC (RP-LC), is extensively used in the separation and structural identification of pharmaceutical samples. However, many parameters have to be considered when a new LC/MS method is developed for either separation and structural analysis of unknown mixtures or quantitative analysis of a set of known compounds in an assay.
View Article and Find Full Text PDFJ Comb Chem
October 2000
Affymax Research Institute, Santa Clara, California 95051, USA.
Combinatorial chemistry is a powerful tool to enhance drug discovery efforts in the pharmaceutical industry. One type of combinatorial chemistry, parallel synthesis, is now widely used to prepare numerous compounds of structural diversity. A novel high-throughput method for quality control of parallel synthesis libraries has been developed.
View Article and Find Full Text PDFStem Cells
October 2000
Affymax Research Institute, Palo Alto, California, USA.
We have screened a variety of L-amino acid peptide libraries against the extracellular domain of the human thrombopoietin (HuTPO) receptor, c-Mpl. A large number of peptide ligands were recovered and categorized into two families. Peptides from each family compete with the binding of HuTPO and with the binding of peptides from the other familiy.
View Article and Find Full Text PDFJ Org Chem
September 2000
Affymax Research Institute, 3410 Central Expressway, Santa Clara, California 95051, USA.
An efficient solid-phase approach has been developed to prepare nitrogen heterocycles with a 1,2,3,4-tetrahydro-2-pyridone core via aza-annulation of enamines. Immobilized enamines were prepared from the reaction of primary amines with propynoic acid derivatives or ketones. Aza-annulation reactions were carried out by reacting resin-bound enamines with symmetrical alpha,beta-unsaturated acid anhydrides or alpha,beta-unsaturated acids in the presence of DPPA and TEA.
View Article and Find Full Text PDFProc Natl Acad Sci U S A
June 2000
Affymax Research Institute, 4001 Miranda Avenue, Palo Alto, CA 94304, USA.
Two series of peptides that specifically bind to the extracellular domain of the alpha chain of the human interleukin-5 receptor (IL-5Ralpha), but share no primary sequence homology to IL-5, were identified from libraries of random recombinant peptides. Affinity maturation procedures generated a 19-aa peptide that binds to the IL-5 receptor alpha/beta heterodimer complex with an affinity equal to that of IL-5 and is a potent and specific antagonist of IL-5 activity in a human eosinophil adhesion assay. The active form of the peptide is a disulfide-crosslinked dimer that forms spontaneously in solution.
View Article and Find Full Text PDF